Adial Pharmaceuticals, Inc ADIL
$3.98
-9.34%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 2026-08-14 | View → |
| 8-K | CURRENT REPORT | 2026-08-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-07-16 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-07-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 8-K | CURRENT REPORT | 2026-06-11 | View → |
| 8-K | CURRENT REPORT | 2026-05-11 | View → |
| 10-Q | QUARTERLY REPORT | 2026-05-08 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 8-K | CURRENT REPORT | 2026-04-09 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 4 | Insider transaction | 2026-04-09 | View → |
| 8-K | CURRENT REPORT | 2026-03-06 | View → |
| 10-K | ANNUAL REPORT | 2026-03-05 | View → |
| 8-K | CURRENT REPORT | 2026-03-03 | View → |
| 8-K | CURRENT REPORT | 2026-02-24 | View → |
| 8-K | CURRENT REPORT | 2026-02-04 | View → |
| 8-K | CURRENT REPORT | 2026-01-06 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-01-06 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2025-12-19 | View → |
| S-3 | REGISTRATION STATEMENT | 2025-12-12 | View → |
| 8-K | CURRENT REPORT | 2025-12-01 | View → |
| 8-K | CURRENT REPORT | 2025-11-14 | View → |
| 10-Q | QUARTERLY REPORT | 2025-11-13 | View → |
| 8-K | CURRENT REPORT | 2025-09-16 | View → |
| 8-K | CURRENT REPORT | 2025-09-03 | View → |
| 8-K | CURRENT REPORT | 2025-08-14 | View → |
| 10-Q | QUARTERLY REPORT | 2025-08-13 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2025-08-01 | View → |
| 8-K | CURRENT REPORT | 2025-08-01 | View → |
| 8-K | CURRENT REPORT | 2025-08-01 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2025-07-31 | View → |
| 8-K | CURRENT REPORT | 2025-07-16 | View → |
| 8-K | CURRENT REPORT | 2025-07-10 | View → |
| 8-K | CURRENT REPORT | 2025-06-18 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.98
- Market Cap
- $9.43 million
- 52-Week Range
- $1.31 – $18.90
- Average Volume
- 56K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.